Published On: Wed, Oct 19th, 2016

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Latest Broker Views


A number of investment brokers have recently updated their price targets on shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX).

Most recent broker ratings

09/29/2016 – IDEXX Laboratories, Inc. had its “neutral” rating reiterated by analysts at Bank of America Merrill Lynch.

08/16/2016 – IDEXX Laboratories, Inc. had its “buy” rating reiterated by analysts at Stifel Nicolaus. They now have a USD 125 price target on the stock.

08/03/2016 – IDEXX Laboratories, Inc. was upgraded to “neutral” by analysts at Northcoast Research.

07/20/2016 – IDEXX Laboratories, Inc. had its “buy” rating reiterated by analysts at Canaccord Genuity. They now have a USD 98 price target on the stock.

04/13/2016 – IDEXX Laboratories, Inc. had its “outperform” rating reiterated by analysts at Credit Suisse. They now have a USD 85 price target on the stock.

04/01/2016 – IDEXX Laboratories, Inc. had its “neutral” rating reiterated by analysts at CL King.

02/01/2016 – IDEXX Laboratories, Inc. had its “neutral” rating reiterated by analysts at Piper Jaffray. They now have a USD 75 price target on the stock.

08/28/2015 – IDEXX Laboratories, Inc. was downgraded to “market perform” by analysts at Raymond James.

07/23/2015 – IDEXX Laboratories, Inc. was upgraded to “hold” by analysts at Feltl & Co..

10/07/2014 – IDEXX Laboratories, Inc. had its “neutral” rating reiterated by analysts at Zacks. They now have a USD 128 price target on the stock.

The share price of IDEXX Laboratories, Inc. (NASDAQ:IDXX) was up +1.17% during the last day of trading, with a day high of 113.12. 344136 shares were traded during the last session.

The stock’s 50 day moving average is 112.26 and its 200 day moving average is 97.24. The stock’s market capitalization is 10.08B. IDEXX Laboratories, Inc. has a 52-week low of 63.48 and a 52-week high of 117.84.

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company’s segments include Companion Animal Group (CAG), which develops, designs, manufactures and distributes products and performs services for veterinarians and the bioresearch market; Water, which develops, designs, manufactures and distributes a range of products used in the detection of various microbiological parameters in water; Livestock, Poultry and Dairy (LPD), which develops, designs, manufactures and distributes diagnostic tests and related instrumentation, and performs services that are used to manage the health status of livestock and poultry and to expand bovine reproductive productivity, and Other, which develops, designs, manufactures and distributes point-of-care electrolyte and blood gas analyzers and related consumable products for the human medical diagnostics market.